glp-1 obesity drug news today october 16 2025 Market The Obesity Drug Boom
Description
Nausea, vomiting, diarrhoea, stomach pain, constipation and headache are among the most common side effects
We know that as HR professionals, youre probably receiving a lot of questions about GLP-1s
Woo YS, Lim HK, Wang SM, Bahk WM
The most frequently reported issues for new patients were nausea, constipation, and GI issues
Accessed October 30, 2025
Moreover, the dose used to treat T2DM and obesity may differ
